April 1, 2022
A new publication from the Fast lab features the discovery of an allosteric inhibitor of New Deli metallo-beta-lactamase for treating CRE through the use of high-throughput screening. For more on this discovery, go to https://pubs.acs.org/doi/10.1021/acsinfecdis.1c00577.